Powered by Google www.ChineseStandard.net Database: 189759 (19 May 2024)

YY/T 1754.2-2020 related PDF English

YY/T 1754.2-2020 (YY/T1754.2-2020, YYT 1754.2-2020, YYT1754.2-2020) & related versions
Standard IDContents [version]USDSTEP2[PDF] delivered inStandard Title (Description)See DetailStatusSimilar PDF
YY/T 1754.2-2020English185 Add to Cart 0-9 seconds. Auto delivery. Preclinical animal study of medical devices -- Part 2: Model of skin defect in induced diabetic rats YY/T 1754.2-2020 Valid YYT 1754.2-2020

Preview PDF: YY/T 1754.2-2020

YY/T 1754.2-2020: PDF in English (YYT 1754.2-2020)
YY/T 1754.2-2020
ICS 11.100.20
C 30
Preclinical animal study of medical devices - Part 2:
Model of skin defect in induced diabetic rats
Issued by: National Medical Products Administration
Table of Contents
Foreword ... 3 
Introduction ... 4 
1 Scope ... 5 
2 Normative references ... 5 
3 Experimental principle ... 5 
4 Apparatus and reagents ... 5 
5 Test animal ... 6 
6 Test process ... 6 
7 Test report ... 8 
Appendix A (Informative) Examples of histological semi-quantitative analysis
methods of model of skin defect in induced diabetic rats ... 9 
Preclinical animal study of medical devices - Part 2:
Model of skin defect in induced diabetic rats
1 Scope
This Part of YY/T 1754 specifies the method for constructing a model of skin
defect in induced diabetic rats.
This Part applies to the evaluation of the preclinical effectiveness of medical
device products for the treatment of skin ulcers and damage caused by diabetes.
2 Normative references
The following documents are indispensable for the application of this document.
For dated references, only the dated version applies to this document. For
undated references, the latest edition (including all amendments) applies to this
GB/T 16886.2, Biological evaluation of medical devices - Part 2: Animal
welfare requirements
3 Experimental principle
Induce rat diabetes by injection of streptozotocin (STZ); excise the back skin of
diabetic rats to construct a skin defect model of diabetic rats.
4 Apparatus and reagents
4.1 Main apparatuses
4.1.1 Electronic weight scale.
4.1.2 Camera.
4.1.3 Microscope.
4.1.4 Blood glucose meter.
4.2 Reagents
4.2.1 Streptozotocin (STZ).
4.2.2 Sodium citrate (analytical reagent).
One day after the successful establishment of the diabetic rat model, begin to
establish the skin injury model. After anesthesia, place the rat on the operating
table, with the back facing up; remove the back hair, to fully expose the back
skin. After routine surgical disinfection, remove the 2 cm × 2 cm full-thickness
skin from the back of the rat (other verified wounds are also available).
6.1.4 Test product sampling
The test rats should be randomly divided into a blank control group, a test
product group, and/or a control product group (such as a commercially available
product); the number of each group shall meet the requirements of statistical
analysis. For the blank control group, only use sterile gauze/applicator to cover
the skin wound on the back of the rat and fix, without other treatment; for the
test product group and/or control group, use the relevant test product and/or
control substance to cover the skin would on the back of the rat, and use sterile
gauze/applicator to cover and fix. All animals are raised in single cages.
Observe the activities and diet of the animals every day, and replace the litter
in time.
6.2 Test result and evaluation
6.2.1 General
The recommended observation period is at least 21 days. Select a reasonable
observation time point according to the product characteristics. At least include
the observation indicators of 6.2.2 ~ 6.2.4.
6.2.2 General wound recovery
It is advisable to roughly judge the recovery of the wound through the exudation,
adhesion and wound retraction of the rat's wound.
6.2.3 Wound healing rate
The time point should be observed after the operation; take pictures of the
wound; use image processing software or other verified software to measure
the wound area. Wound healing rate is the ratio of the difference between the
original wound area and the unhealed area of the wound to the original wound
area. See Formula (1) for the calculation of wound healing rate:
R -- Wound healing rate;
A0 -- Original area of the wound, in square centimeters (mm2);

Standard ID YY/T 1754.2-2020 (YY/T1754.2-2020)
Description (Translated English) Preclinical animal study of medical devices -- Part 2: Model of skin defect in induced diabetic rats
Sector / Industry Medical Device & Pharmaceutical Industry Standard (Recommended)
Classification of Chinese Standard C30
Classification of International Standard 11.100.20
Word Count Estimation 8,838
Date of Issue 2020-09-27
Date of Implementation 2021-09-01
Drafting Organization China Institute of Food and Drug Control, Shandong Medical Device Product Quality Inspection Center, Jinan Pansheng Biotechnology Co., Ltd.
Administrative Organization National Standardization Technical Committee for Biological Evaluation of Medical Devices (SAC/TC 248)
Regulation (derived from) Announcement No. 108 (2020) of the National Medical Products Administration
Proposing organization State Drug Administration
Issuing agency(ies) State Drug Administration